OVERVIEW

Advances in diagnosis & treatment for aplastic anemia is organized by Springer Healthcare IME.

Description:
The Q&A session is guided by questions we received from you, our audience. Watch the experts discuss these, and other important topics.

Please take a moment to complete the feedback form after viewing.

This program is designed for global hematologists and all healthcare professionals managing AA patients.

Aplastic anemia (AA) is a rare hematologic disease characterized by a reduced production of blood cells. Significant advances in treatment options have been made, but there are associated complications. The disease burden remains high, and quality of life is often substantially compromised, but early diagnosis can dramatically improve patient outcomes.

This independent educational program aims to raise awareness among healthcare professionals and highlight advances in the diagnosis, treatment, and management of patients with AA that have the potential to improve patients’ outcomes and quality of life.